The susceptibility of highly purified human CD34+ cells t o monocytotropic (Ba-L) and lymphotropic (AOl8-post) strains of human immunodeficiency virus-1 (HIV-1) was examined. Liquid cultures initiated with fresh immunomagnetically purified CD34+ cells using the K6.1 CD34 monoclonal antibody (MoAb) (K6.1/CD34+) were positive for HIV expression 2 weeks after exposure t o HIV-1 Ba-L. These cells were initially greater than 90% CD34+ and had undetectable monocyte contamination by flow-cytometric staining and side-scatter analyses, respectively, and undetectable T-cell contamination by CD3 polymerase chain reaction (PCR) analysis. However, secondary CD34+ liquid cultures reselected from the primary liquid cultures 24 hours after HIV exposure by panning with the ICH3 CD34 MoAb (ICH3/CD34+) and maintained for an additional 14 days were negative for HIV expression. The ICH3-unbound cells were positive for both spliced and unspliced HIV RNA when exposed t o HIV-1 Ba-HE CD34 ANTIGEN is expressed on primitive human
L, and were DNA PCR positive when exposed t o either monocytotropic or lymphotropic HIV-1. To further test that CD34+ cells were not infectible by HIV-1, we exposed K6.11 CD34" cells continuously t o HIV-1 in a culture system capable of maintaining and expanding primitive CD34+ cells. HIVexposed K6.1/CD34+ cells proliferated and expanded as efficiently as uninfected cultures. However, when reselected magnetically using the K6.1 CD34 MoAb after expansion for 7 days, bound K6.1/CD34+ cells were again negative for HIV-1 expression, whereas unbound cells were positive for HIV-1 expression. These findings suggest that a sequential CD34+ cell-selection process, in which the two selections are separated by a brief culture period, can yield a population of CD34+ cells that are not infected with HIV-1. This process may be useful in the design of stem or progenitor cell-based transplantation therapies for HIV infection. 0 1996 by The American Society of Hematology.
proposed that HIV-1 affects hematopoiesis indirectly, through infection of the accessory cells (stromal cells, monocytes, and/ view is supported by the observation that CD34' cells from most patients are not HIV-infected,l"'h"9 suggesting that direct HIV-1 infection of CD34+ cells is not responsible for the hematopoietic suppression observed in infected individuals.
CD34+ cells are a heterogeneous population of hematopoietic precursors at different stages of differentiation. In culture, CD34+ cells will mature into CD34-monocytic lineages known to be susceptible to HIV-1 infection.2" The purpose of this study is to resolve whether primitive hematopoietic CD34+ BM cells or differentiated hematopoietic precursors are susceptible to HIV-1 infection. To accomplish this, we devised a two-step CD34' cell-purification procedure in which CD34+ cells are purified, exposed to HIV-1, and then repurified for the CD34+ phenotype. Results obtained using this procedure indicate that primitive CD34' cells are not susceptible to HIV-1 infection.
or T cells) required for hematopoietic regulati~n?.~.'~-'~ This

MATERIALS AND METHODS
K6
.I-magnetic bead isolation. BM cells were obtained either from cadavers or from the posterior iliac crest of live patients under local anesthesia under a protocol approved at Walter Reed Army Institute of Research, and were subjected to the CD34+ cell-isolation procedure as previously described.?' Briefly, BM aspirates were collected into a 20-mL syringe containing EDTA as an anticoagulant. BM cells were diluted 1 :2 with phosphate-buffered saline (PBS) and subjected to Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden) density gradient centrifugation. Interphase mononuclear cells were washed twice in PBS and further purified by magnetic bead immunoselection using biotinylated high-affinity CD34 monoclonal antibody (MoAb) K6.1 and anti-biotin-modified Dynal beads (Dynal, Skeyen, Norway). After magnetic selection, beads were detached from CD34' cells by displacement with soluble biotin.
To better accommodate the low cell numbers after CD34' cell selections, reselections were performed in 25-cm2 AIS MicroCELLector flasks (Applied Immune Sciences Inc, Santa Clara, CA) in which an MoAb that recognizes the ICH3 isotype of the CD34 antigen was covalently immobilized?* Briefly, magnetic bead-isolated CD34' cells were suspended in 0.5% human gammaglobulin and 0.5 mmol/L EDTA in PBS for 15 minutes, followed by incubation of cells on an anti-CD34 AIS flask for I hour at room temperature. Unbound cells were removed, and cells bound to the AIS CD34 flask were recovered by agitating the flask in the presence of 10% fetal calf serum (FCS) in PBS. Cells not bound to AIS flasks are referred to as ICH3-unbound, and cells bound to the surface of the AIS flasks are referred to as ICH3/ CD34'. CD34+ cells ( I X I06/mL) were cultured at 37°C and 5% COz with Iscove's modified Dulbecco's medium ([IMDM] GIBCO, Grand Island, NY) supplemented with 20% FCS and 10% GCT-conditioned medium (GCTCM), as a source of colony-stimulating activity, in 24-well plates. GCTCM was prepared by growing GCT cells in IMDM with 20% heat-inactivated FCS to confluency over a period of 10 days. Media were collected and clarified by passing through a 0.45-pm filter. GCT (American Type Culture Collection, Rockville, MD) is a human bladder carcinoma cell line capable of producing various growth factors required for progenitor cell proliferati~n."~~~ CD34+ cells (0.5 X IO6) obtained from the different isolation procedures were resuspended in 0.5 mL undiluted HIV-I AOlS-post, titrating 970 TCID,dmL (tissue CD34+ cell culrures.
HIV-1 infection of CD34' cells.
culture infectious dose 50%). or HIV-I Ba-L, titrating 1 X IO6 TCIDsdmL, in the presence of 10% GCTCM at 37°C overnight (16 to 24 hours). HIV-I AOIS-post is an AZT-resistant HIV-I isolate, donated by Dr Douglas Richman to the National Institute of Allergy and Infectious Diseases AIDS Reference Reagent Repository. The HIV-I AOl8-post isolate was expanded in PB mononuclear cells (PBMC) whereas the HIV-I Ba-L isolate was expanded in monocyte/ macrophage cultures. Both HIV-I isolates were titrated using the ATCGlDoD consensus prot~col.'~ In experiments in which the anti-CD4 MoAb was used, cells were pretreated with 10 pL OKT4a (Ortho, Raritan, NJ) for 1 hour before addition of the HIV-I inoculum. The next day, the cells were washed three times in PBS, resuspended at 0.5 x IOh/mL in IMDM supplemented with 20% FCS and 10% GCTCM, and then cultured at 37°C. The cells were fed twice per week by replacing half of the spent media with fresh media. After 14 days, culture supernatants were analyzed for the presence of HIV p24 antigen production by enzyme-linked immunosorbent assay (Coulter, Kendall, FL) according to the manufacturer's protocol, and cells were processed for the isolation of either RNA or DNA as described later herein. Cells (0.2 x IO') were washed in sort buffer containing 0.5% bovine serum albumin and 0.05% sodium azide (NaN,) in PBS, followed by incubation at 4°C with 20 pL anti-CD33-PE. anti-CD38-PE. or anti-CD4-PE MoAbs and anti-CD34-FITC (HPCA-2; Becton Dickinson, San Jose, CA) for 20 minutes.
The cells were washed with 2 mL sort buffer, centrifuged, and resuspended in 100 pL sort buffer and 100 pL 1.0% formaldehyde. Fluorescent cells were analyzed by collecting 10, OOO events on a Coulter Elite-ESP using Elite software.
CD34' cells were cultured in liquid suspension cultures overnight with or without HIV-I exposure, as described earlier. A triplicate set of 1 X IO? cells were then cultured in 0.6% methylcellulose in IMDM supplemented with 30% FCS, 10% GCTCM, 2.5 U erythropoietin (Amgen Biologicals, Thousand Oaks, CA), penicillin (100 UlmL), and streptomycin (100 pg/mL) in 35-mm gridded petri dishes. The dishes were incubated at 37°C in a humidified atmosphere with 5% C02. After 14 days, colony-forming unit-granulocytelmacrophage (CFU-GM), burst-forming unit-erythroid (BFU-E), and mixed CFU (CFUmix) colonies were counted under an inverted-phase microscope according to established criteria. Briefly, colonies containing both granulocytes and macrophages were considered CFU-GM. Colonies containing only erythroid cells were considered BFU-E. Colonies containing both CFU-GM and BFU-E were considered CFU-mix. Colonies were assigned to groups based on their morphologic appearance and the individual cells within them. For DNA polymerase chain reaction (PCR) analysis of methylcellulose colonies, the entire culture was diluted in PBS, and the cells were resuspended in PBS, washed by centrifugation, and processed as described later herein.
Purified CD34' cells with or without HIV-I were expanded in vitro as described by Davis et a]." Briefly, 0.5 X 10' cells were cocultured on a subconfluent (70% to 80% confluent) porcine brain microvascular endothelial cell (PMVEC) monolayer containing hematopoietic growth media (IMDM supplemented with 10% FCS, 2 ng/mL granulocyte-macrophage colonystimulating factor, 5 ng/mL interleukin-3 [IL-3], 120 ng/mL stem cell factor (SCF), 5 ng/mL IL-6, 100 UlmL penicillin/streptomycin, and 100 pg/mL L-glutamine). Cultures were incubated at 37°C and were fed after 5 days. After 7 days of culture, nonadherent cells (20-to 30-fold increased) were removed from the PMVEC monolayers, and expanded CD34' cells (threefold to eightfold) were selected by the K6.1 -magnetic bead CD34' cell-isolation procedure, and in some experiments followed by the ICH3 antibody-coated flasks, as described earlier.
Samples for DNA PCR were prepared by lysing 1
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ICH3-unbound
Sequentially purified CD34' cells (1.000 cells) were plated in methylcellulose in the presence of 10% GCTCM. Colonies were scored after 2 weeks. Values are the mean of triplicate wells, and data are representative of 6 independent experiments. K6.1-magnetic bead-isolated CD34' cells were subjected to a second round of selection using ICH3 antibody-coated flasks, resulting in bound (ICH3/CD34') and unbound (ICH3-unbound) cell populations. in a total volume o f 30 pL. The amplification profile included a preheating step for 3 minutes at 94°C. followed hy 30 cycles o f a 94°C denaturation segment for I minute, a 60°C annealing segment for I minute, and a 72°C extension segment for 3 minutes: the cycles were followed by final extension at 72°C for 7 minutes. Amplified products were resolved on a 1.25% agarose gel, followed by a Southem blot transfer to Nylon-I membrane (GIBCO-BRL. Gaithersburg, MD). Blots were then hybridized with gene-specific oligonucleotide probes labeled with [y"P]ATP. End-labeling o f oligonucleotides was performed in a 25-pL reaction volume containing 300 mmol/L Tris hydrochloride (pH 7.8). 75 mmol/L 2-mercaptoethanol. 50 mmol/L MgCl?. 20 p C i [y"P]ATP, 10 U T 4 polynucleotide kinase (GIBCO-BRL), and 50 ng oligonucleotides. After 1 hour at 37"C, the reaction was stopped by adding I pL 0.5-mol/L Na,EDTA, followed by purification on a spin column (Clontech Laboratories Inc, Palo Alto, CA). Blots were exposed to x-ray films and quantified directly from the nylon membrane using a Phosphorlmager scanner with ImageQuant software from Molecular Dynamics (Sunnyvale, CA). Quantitative dilution curves to show that the PCR signals are in the linear range o f the PCR reaction were formed by making an appropriate mix o f purified D N A from H I V -I -infected (ACH-2) and -uninfected (A3.01) cells.
Reverse transcriptase-f CR. Total RNA was extracted from cells by RNAzol (Tel Test Inc. Friendswood, TX) as specified by the manufacturer. Two micrograms o f total RNA were treated with 10 U DNase-I for 15 minutes at room temperature, followed by 10 minutes at 95°C to inactivate the enzyme. One microliter of random @actin HIV (unspliced) HIV (spliced) C. hexamer primers was added, and the mixture was heated to 65°C for 10 minutes, followed by a quick chill on ice. 
RESULTS
Phenotypic and functional analyses of sequentially selected CD34' cells. BM CD34' cells were initially isolated by immunomagnetic selection with CD34 MoAb K6.1 (K6.1KD34') and then reanalyzed for purity by flow cytometry after staining with FITC-conjugated HPCA-2 CD34 MoAb. Approximately 90% of the selected cells were antigen-positive, and virtually all of the remaining cells had similarly low side-scatter indicative of lymphoblastoid, not monocytic, morphology (Fig 1) . In previous studies using this isolation method, we showed that greater than 98% of cells were CD34' when stained with PE-conjugated HPCA-2 MoAb for greater sen~itivity.','~ The cells were then reselected for CD34 expression by panning in tissue culture flasks coated with CD34 MoAb ICH3, resulting in bound (ICH3KD34') and unbound (ICH3-unbound) fractions that comprised approximately 40% and 60% of the cells, respectively.
The mechanism for this separation by panning is unclear. Both K6.1 and ICH3 MoAbs recognize class I epitopes on the CD34' molecule, but the epitopes are chemically distinct. 26 .2b Staining and reanalysis of these cell fractions for CD34 expression showed them to be of similar purity and antigen density (Fig 1, first column) . There was undetectable T-cell contamination in both the ICH3KD34' and ICH3-unbound cells, but detectable monocytehacrophage lineage differentiation in ICH3-unbound cells as determined by CD3 and CD14 RT-PCR analysis, respectively (data not shown). To resolve other differences between the fractions, the cells were also stained and analyzed for expression of the maturation-associated antigens, CD33 (Fig I , second column) and CD38 (Fig 1, third column) . A greater proportion of ICH3-bound cells (ICH3KD34') were CD33-dim or CD33-than in the unbound fraction (ICH3-unbound), but there was considerable overlap in the populations. There was little difference in CD38 expression. Using flow cytometry, we were unable to detect CD4 expression on any CD34' cell populations analyzed (data not shown).
To detect possible functional differences between the two fractions, cells were plated in colony-forming assays. The number of BFU-E and CFU-GM in both fractions was statistically similar (Table I) .
HIV-I exposure of CD34' cell populations in liquid cultures. Exposure ( I 6 to 24 hours) of K6. IKD34' cells to HIV-I Ba-L and growth in liquid culture media containing 10% GCTCM for 2 weeks resulted in HIV-I expression (data not shown). Similarly, both ICH3/CD34' and ICH3-unbound liquid cultures exposed (16 to 24 hours) to HIV-I (Fig 2A) resulted in the detection of both unspliced (fulllength, across primer-binding site) and spliced (tat-rev-nef)" expression of HIV-I RNA by RT-PCR after 2 weeks in culture (Fig 2B, lanes 3 and 6) . HIV expression in these cultures could be blocked by addition of OKT4a antibodies, suggesting the presence and requirement of cells expressing the CD4 surface receptor molecule in both the ICH3KD34' and ICH3-unbound cell populations (Fig 2B. lanes 2 and 5) . RT-PCR analysis of HIV-1 unspliced (full-length) and spliced (tar-rev-ne0 RNA from sample cultures 1,3, and 4 as described in A. RNA was isolated from 14-day cultures, reverse-transcribed, and amplified for p-actin (to control for the amount of RNA amplified), HIV-1 unspliced, and HIV-1 spliced RNA. The gels were blotted and probed for specific internal sequences. These samples were reverse-transcribed, amplified, and probed together with the ACH-2 RNA titration shown in Fig  2C. showing that the sample signals are in the linear range of the PCR reaction. The autoradiogram is a dhour exposure on Kodak XAR film, and is representative of at least 3 independent experiments. IC) DNA PCR analysis of HIV-1 genomic DNA from sample cultures 1 t o 6. DNA was isolated from 14-day cultures and amplified for p-actin (to control for the amount of DNA amplified) and HIV-1 full-length DNA sequences. These samples were amplified and probed together with the ACH-2 DNA titration shown in Fig 38, showing that the sample signals are in the linear range of the PCR reaction. The autoradiogram is a 4-hour exposure on Kodak XAR film, and is representative of at least 3 independent experiments.
Addition of transcriptional activators, either TNF-a or PMA, after HIV-I exposure increased HIV expression. TNF-a added to cultures at 7 days increased p24 antigen production at 12 days from 80 pg/mL to 20,000 pg/mL. In similar experiments, addition of PMA to cultures at 7 days increased p24 antigen production at 14 days from 15,000 pg/mL to 50,000 pg/mL. These experiments suggest active HIV replication in CD34-derived liquid cultures after virus exposure.
On the other hand, in the same experiments, colonies grown in methylcellulose were not infected by HIV-I. Methylcellulose colonies derived from either ICH3/CD34' or ICH3-unbound cultures exposed to HIV-I Ba-L showed no evidence for the presence of the HIV genome when analyzed by DNA PCR (Fig 3A) . It is not clear whether HIV-1-infected progenitor cells could form colonies in methylcellulose, but HIV-I exposure of both the ICH3/CD34' and ICH3-unbound cultures did not affect the number or size of the colonies formed ( Table I ). The number of colonies in HIV-1 -exposed methylcellulose cultures was never less than in the unexposed or OKT4a-blocked HIV-1 -exposed cultures, suggesting that progenitor cells either are uninfectible by HIV-I or are below DNA PCR detection limits.
Reselection of CD34' cells from liquid cultures of HIV-
I -infected K6. I/CD34+ cells. Considering that cellular differentiation of CD34' cells to susceptible cells2' might occur during HIV exposure, we reselected CD34' cells from primary liquid cultures of K6.1/CD34' cells 24 hours after HIV-I Ba-L exposure (Fig 4A) . The resulting secondary cultures, ICH3/CD34' and ICH3-unbound, were cultured for 14 days and analyzed for HIV-I expression by RT-PCR. Whereas the ICH3-unbound population was positive for both unspliced and spliced HIV RNA expression (Fig 4B, lane  4) , HIV expression was not detected in the ICH3/CD34' cell population (Fig 4B, lane 3) .
In agreement, DNA PCR analysis of HIV-I -exposed primary K6. I/CD34' cultures with either the monocytotropic HIV-I Ba-L or the lymphotropic HIV-I AO18-post, after CD34' cell reselection (after 24 hours), showed no evidence of the HIV-I genome in the ICH3/CD34+ cell population (Fig 4C, lanes 3 and 5) . Only ICH3-unbound cultures were positive for the HIV-I genome (Fig 4C, lanes 4 and 6) . These data confirm that a subpopulation of CD34' cells that were reselected by the ICH3 MoAb after virus exposure were not susceptible to HIV-I infection.
To address whether actively dividing CD34' cells could support HIV-1 replication, K6. I/CD34' cells were exposed to HIV-I Ba-L and cultured in a PMVEC CD34' cell expansion system2' in the presence of granulocyte-macrophage colonystimulating factor, IL-3, SCF, and IL-6 for 7 days. Over the incubation period, the growth and number of cells retrieved from HIV-I -infected and -uninfected cultures were identical. Uninfected cultures had p24 antigen values less than background, whereas cultures exposed to HIV-1 had p24 values at day 7 greater than 500 pg/mL, suggesting active HIV replication in HIV-exposed PMVEC cultures. CD34' cells in these cultures were reselected using the K6.1-magnetic bead method to obtain a more quantitative recovery of CD34' cells (Fig 5A) . On reselection, both the HIV-I-
Expansion of CD34' cells afrer exposure to HIV-I.
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From infected and -uninfected cultures showed the same 4.6-fold expansion of CD34' cells. The secondary-selected K6. I/ CD34' and K6.1/CD34-cells were recultured for an additional 7 days before analysis for HIV-I expression. RT-PCR analysis showed expression of unspliced HIV-I RNA in K6.I/CD34-cultures (Fig 5B, lane 4) , but no HIV-I expression was detected in K6.1/CD34' cultures (Fig 5B,   lane 3) . Thus, despite proliferation and continuous exposure to HIV-I, CD34' cells appear not to be susceptible to HIV-1 infection.
DISCUSSION
Conflicting reports exist regarding the susceptibility of CD34' cells to HIV-I infection. In an attempt to resolve this issue, we performed sequential selections of bone marrowderived CD34' cells for the CD34' phenotype. Initially, we infected CD34' cells with HIV-I after sequential selection magnetically and by panning using the K6.1 and ICH3 MoAb, respectively. Under these conditions, the cultures were positive for HIV-1 expression. However, the lack of the HIV-I genome within the human progenitor cell colonies derived from HIV-I -infected cultures was in contrast to the HIV-1 infection of sequentially selected cells. Therefore, to rule out cellular differentiation during exposure of CD34' cells to HIV-I, we reselected for the CD34' marker after exposure of the cells to HIV-I. When the reselection was made after HIV-I exposure, CD34' cells were negative for HIV-I infection.
Little is currently known about the rate of proliferation and self-renewing properties of human stem cells or primitive progenitor cells. These may differ substantially from the rapid concurrent proliferation and differentiation observed for more mature progenitor cells. This, coupled with the fact that HIV-1 replicates best in actively dividing cells,28 raises the possibility that a brief exposure of CD34' cells to HIV-1 might not be adequate to productively infect a cell with an unknown cycling time. Therefore, we exposed CD34' cells to HIV-I in a culture system that preferentially expands primitive CD34' cells and allowed the cells to grow for 7 days in the continuous presence of virus. Even under these conditions, the expansion and self-renewing properties of primitive CD34' cells were the same in the presence or absence of HIV-1. In addition, reselected CD34' cells from these cultures were negative for HIV-I expression.
HIV-I infection of sequentially selected K6. I/CD34' and ICH3/CD34' cells in our initial experiments was inhibited by OKT4a antibodies, showing that HIV-I infection was occurring though the CD4 surface antigen.29 We have been unable to detect CD4 expression by flow analysis on any of the CD34' cell preparations. The OKT4a-blocking experiments suggest that either the reselected HIV-I -exposed For personal use only. on October 22, 2017. by guest www.bloodjournal.org From ICH3/CD34+ cells lack CD4 surface expression or are missing the additional factors required for HIV-1 infection. Furthermore, either the CD4 surface expression or the additional factors are acquired during HIV-1 exposure and, if not reselected by panning, will become infectible and express HIV-I . Susceptibility of ICH3/CD34+ cells during exposure to HIV-1 infection could be induced by a cytokine(s) present in the GCT-conditioned media, similar to that observed for IL-3 induction of the IL-2 receptor on early myeloid cells.3" With respect to the HIV-1 infection experiments, it is clear that HIV-1 is not infecting CD34+ cells that are reselected after HIV-1 exposure. The identity of the HIV-1 -infectible cell in the ICH31CD34' cell population during incubation with HIV-1 is presently unknown; however, the infected cell appears in long-term stromal cultures and may be a cell type present in the stromal micr~environment.~'
The p24 antigen and RT-PCR analyses were consistent with HIV-1 expression occurring in differentiated cells. During the first 12 days of culture, HIV-infected CD34' cells showed background levels of p24 antigen production. Addition of TNF-a or PMA at day 7 enhanced HIV expression, but whether this was caused by HIV-LTR activation or accelerated differentiation of primitive cells to mature cells is not known. It is possible that inducers in the cell culture system itself or the HIV-1-encoded proteins, vpr and/or fat, cause a rapid differentiation of HIV-1 -infected primitive CD34' cells, preventing their reselection with the ICH3 MoAb. Such differentiation would be similar to what was observed in rhabdomyosarcoma cells" and rat pheochromocytoma (PC12) cells,33 respectively. Nor do we believe that signaling through the CD34 surface caused by binding of the K6.1-magnetic bead-purified cells to the ICH3 antibody-coated flasks, interferes with HIV-1 expression, because CD34 cells sequentially purified (K6. l , then ICH3 monoclonal antibody) and HIV-I -exposed resulted in HIV expression.
In conclusion, we have shown that CD34' cells might be deemed infectible or noninfectible by HIV-1, depending on the sequence of cell selection in culture and infection. When CD34' cells were reselected for CD34+ phenotype after exposure to HIV-1, no HIV-1 infection was detected. Although this needs to be confirmed in HIV-infected patients, in vitro data reported herein suggest that this procedure may be useful to purge HIV genome-containing cells from HIV-infected marrow. CD34' cells from HIV-infected patients could therefore be obtained free of HIV and used in gene therapy protocols for autologous CD34+ cell transplantation aimed at introducing an anti-HIV-1 therapeutic gene into stem cells. This would render the progeny of these cells resistant to HIV-1 infection and allow reconstitution of the immune system.
